Prerecovery liver biopsy in the brain‐dead donor: A case‐control study of logistics, safety, precision, and utility

Joseph Benton Oliver, Stephen Peters, Advaith Bongu, Abdel‐Kareem Beidas, George Dikdan, Lloyd Brown, Baburao Koneru – 31 October 2013 – Prerecovery liver biopsy (PLB) can potentially to decrease futile recovery and increase utilization of marginal brain‐dead donor (BDD) livers. A case‐control study was conducted to examine the logistics, safety, histological precision, and liver utilization associated with PLB in BDDs. Twenty‐three cases between January 2008 and January 2013 were compared to 2 groups: 48 sequential and 69 clinically matched controls.

Hepatitis C disease severity in living versus deceased donor liver transplant recipients: An extended observation study

Norah A. Terrault, R. Todd Stravitz, Anna S.F. Lok, Greg T. Everson, Robert S. Brown, Laura M. Kulik, Kim M. Olthoff, Sammy Saab, Ovedele Adeyi, Curtis K. Argo, Jay E. Everhart, Del R. Rodrigo, the A2ALL Study Group – 31 October 2013 – Donor factors influence hepatitis C virus (HCV) disease severity in liver transplant (LT) recipients. Living donors, because they are typically young and have short cold ischemic times, may be advantageous for HCV‐infected patients.

Subscribe to